StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Zomedica's operating cash flow for the twelve months ending Jun 30, 2026 was -$13.37M. For fiscal 2025 it was -$17.65M. The highest annual figure on record is -$4.56M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$17.65M–
FY2024Dec 31, 2024-$23.63M–
FY2023Dec 31, 2023-$15.98M–
FY2022Dec 31, 2022-$11.67M–
FY2021Dec 31, 2021-$14.28M–
FY2020Dec 31, 2020-$16.24M–
FY2019Dec 31, 2019-$15.63M–
FY2018Dec 31, 2018-$11.15M–
FY2017Dec 31, 2017-$7.09M–
FY2016Dec 31, 2016-$4.56M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.55M–
Q1 FY2026Mar 31, 2026-$5.26M–
Q4 FY2025Dec 31, 2025-$899.00K–
Q3 FY2025Sep 30, 2025-$4.66M–
Q2 FY2025Jun 30, 2025-$5.44M–
Q1 FY2025Mar 31, 2025-$6.65M–
Q4 FY2024Dec 31, 2024-$4.53M–
Q3 FY2024Sep 30, 2024-$4.80M–
Q2 FY2024Jun 30, 2024-$6.72M–
Q1 FY2024Mar 31, 2024-$7.59M–
Q4 FY2023Dec 31, 2023-$5.02M–
Q3 FY2023Sep 30, 2023-$3.03M–
Q2 FY2023Jun 30, 2023-$3.68M–
Q1 FY2023Mar 31, 2023-$4.26M–
Q4 FY2022Dec 31, 2022-$2.38M–
Q3 FY2022Sep 30, 2022-$2.77M–
Q2 FY2022Jun 30, 2022-$4.05M–
Q1 FY2022Mar 31, 2022-$2.47M–
Q4 FY2021Dec 31, 2021-$4.90M–
Q3 FY2021Sep 30, 2021-$5.00M–
Q2 FY2021Jun 30, 2021-$1.74M–
Q1 FY2021Mar 31, 2021-$2.64M–
Q4 FY2020Dec 31, 2020-$2.68M–
Q3 FY2020Sep 30, 2020-$5.66M–
Q2 FY2020Jun 30, 2020-$5.72M–
Q1 FY2020Mar 31, 2020-$2.17M–
Q4 FY2019Dec 31, 2019-$1.87M–
Q3 FY2019Sep 30, 2019-$3.91M–
Q2 FY2019Jun 30, 2019-$8.44M–
Q1 FY2019Mar 31, 2019-$2.58M–
Q4 FY2018Dec 31, 2018-$3.33M–
Q3 FY2018Sep 30, 2018-$3.37M–
Q2 FY2018Jun 30, 2018-$2.74M–
Q1 FY2018Mar 31, 2018-$1.71M–
Q4 FY2017Dec 31, 2017-$1.98M–
Q3 FY2017Sep 30, 2017-$1.44M–
Q2 FY2017Jun 30, 2017-$2.11M–
Q1 FY2017Mar 31, 2017-$1.55M–

More Zomedica figures

See a number that looks wrong?